Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease

被引:10
|
作者
Balakrishnan, Amritha [1 ]
Gloude, Nicholas [2 ]
Sasik, Roman [3 ]
Ball, Edward D. [4 ]
Morris, Gerald P. [1 ]
机构
[1] Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr,MC 0612, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Ctr Computat Biol & Bioinformat, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
T cell; Chronic graft-versus-host disease; T cell receptor; TCR; FOLLICULAR HELPER-CELLS; NEGATIVE SELECTION; DE-NOVO; TRANSPLANTATION; EXPRESSION; CD4(+); TCR; REPERTOIRE; ANTIGENS; AUTOIMMUNITY;
D O I
10.1016/j.bbmt.2017.07.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Defective post-transplantation thymopoiesis is associated with chronic graft-versus-host disease (GVHD), a multiorgan pathology affecting up to 80% of patients after allogeneic hematopoietic stem cell transplantation (HSCT). Previous work demonstrated that the subset of T cells expressing 2 T cell receptors (TCRs) is predisposed to alloreactivity, driving selective and disproportionate activity in acute GVHD in both mouse models and HSCT patients. Here we investigate a potential role for this pathogenic T cell subset in chronic GVHD (cGVHD). HSCT patients with cGVHD demonstrated increased numbers of dual TCR cells in circulation. These dual receptor cells had an activated phenotype, indicating an active role in cGVHD. Notably, single-cell RNA sequencing identified the increased dual TCR cells in cGVHD as predominantly expressing Tbet, indicative of a proinflammatory phenotype. These results identify dual TCR cells as specific mediators of pathogenic inflammation underlying cGVHD and highlight Tbet-driven T cell function as a potential pathway for potential therapeutic targeting. (C) 2017 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:1852 / 1860
页数:9
相关论文
共 50 条
  • [21] Recipient γδ T cells in graft-versus-host disease -: Response
    Ferrara, JLM
    Reddy, P
    BLOOD, 2006, 107 (09) : 3809 - 3809
  • [22] AUTOREACTIVE T-CELLS AND GRAFT-VERSUS-HOST DISEASE
    PLAYFAIR, J
    IMMUNOLOGY TODAY, 1990, 11 (04): : 107 - 107
  • [23] Graft-versus-Host Disease Modulation by Innate T Cells
    Fang, Ying
    Zhu, Yichen
    Kramer, Adam
    Chen, Yuning
    Li, Yan-Ruide
    Yang, Lili
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [24] Regulatory T Cells in Graft-versus-Host Disease REPLY
    Koreth, John
    Ritz, Jerome
    Soiffer, Robert J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 963 - 963
  • [25] Follicular Graft-Versus-Host Disease: A Rare Manifestation of Chronic Cutaneous Graft-Versus-Host Disease
    Marti, Nuria
    Martin, Jose M.
    Monteagudo, Carlos
    Lopez, Veronica
    Jorda, Esperanza
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2008, 30 (06) : 620 - 621
  • [26] Rituximab for chronic graft-versus-host disease
    Nair, G.
    Schanz, U.
    Stuessi, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S139 - S139
  • [27] CHRONIC SCLERODERMATOUS GRAFT-VERSUS-HOST DISEASE
    MULLERSERTEN, B
    VAKILZADEH, F
    HAUTARZT, 1994, 45 (11): : 772 - 775
  • [28] Rehabilitation in Chronic Graft-Versus-Host Disease
    Smith, Sean Robinson
    Asher, Arash
    PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, 2017, 28 (01) : 143 - +
  • [29] Chronic graft-versus-host disease and seizure
    Azuno, Y
    Yaga, K
    Kaneko, T
    Kaku, K
    Oka, Y
    BLOOD, 1998, 91 (07) : 2626 - 2628
  • [30] Ruxolitinib for Chronic Graft-versus-Host Disease
    Shibusawa, Motoharu
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1631 - 1631